MOTS-c (Mitochondrial-Derived Metabolic Peptide)
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA gene — one of a small class of peptides originating from the mitochondrial genome rather than the nuclear genome. It functions as a metabolic regulator that activates AMPK signaling, improves insulin sensitivity, enhances mitochondrial efficiency, and mimics some cellular effects of exercise. Evidence Grade: B, primarily from animal studies with limited human data emerging.
Overview
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) was identified in 2015 by Changhan David Lee at USC. It represents a paradigm shift in peptide biology — a bioactive peptide encoded not in nuclear DNA but in mitochondrial DNA, suggesting mitochondria communicate with the rest of the cell through peptide hormones in addition to traditional energy and metabolite signaling.
Plasma MOTS-c levels decline with age and are lower in obese, insulin-resistant individuals — mirroring the metabolic decline associated with mitochondrial dysfunction in aging. Exercise acutely increases circulating MOTS-c, suggesting it may be one mechanism by which physical activity improves systemic metabolism.
Animal studies show remarkable metabolic effects: MOTS-c prevents diet-induced obesity, improves glucose tolerance independently of weight, extends lifespan in aged mice, and enhances endurance exercise capacity. Human trials are in early phases but support the same directional effects.
Mechanism of Action
MOTS-c's primary cellular target is AMPK (AMP-activated protein kinase), the master energy sensor of the cell. MOTS-c crosses from mitochondria to the cytoplasm (and can enter the nucleus under stress conditions), where it activates AMPK by accumulating endogenous AMPK activators including AICAR (5-aminoimidazole-4-carboxamide ribonucleotide).
AMPK activation downstream promotes GLUT4 translocation to the cell surface (increasing glucose uptake in muscle without insulin), stimulates fatty acid oxidation in mitochondria, inhibits mTOR-mediated anabolic signaling (reducing unnecessary biosynthesis under energy stress), and activates mitochondrial biogenesis via PGC-1α. These combined effects recapitulate key metabolic benefits of aerobic exercise at the molecular level.
Under metabolic stress, MOTS-c can translocate to the nucleus and regulate gene expression related to antioxidant defense (Nrf2 pathway) and inflammation. In aging research, MOTS-c has been shown to inhibit senescence-associated secretory phenotype (SASP) in aged cells, potentially connecting mitochondrial peptide signaling to the broader senolytic research landscape.
Research Protocol B
| Parameter | Standard | Notes |
|---|---|---|
| Dose | 5 mg 2x/week | Some use 0.5–1 mg/day; human data limited |
| Route | SubQ | IV also studied; SubQ standard |
| Timing | Before exercise (if applicable) | Exercise may amplify effects |
| Cycle | 8–12 weeks | No defined optimal cycle established |
| Reconstitution | 5 mg in 1 mL BAC water | = 5 mg/mL; 1 mL = 5 mg dose |
Side Effects & Safety
- Safety profile appears favorable based on animal data and limited human experience
- Injection site reactions (mild, common)
- Theoretical: excessive AMPK activation could interfere with anabolic signaling (mTOR inhibition)
- No documented hormonal suppression
- Human long-term safety data absent — use is experimental
Clinical Evidence
Discovery paper. Demonstrated MOTS-c activates AMPK via AICAR accumulation, prevents diet-induced obesity in mice, improves insulin sensitivity, and enhances exercise endurance. Established MOTS-c as a mitochondrial hormone.
Demonstrated exercise acutely elevates MOTS-c in human plasma, establishing it as a bona fide exercise-regulated hormone. MOTS-c levels correlated with exercise intensity and metabolic improvements.
Showed MOTS-c administration reversed age-related insulin resistance in 18-month-old mice, improving glucose tolerance and energy expenditure without affecting food intake.
Stacking Recommendations
| Stack Partner | Synergy |
|---|---|
| AOD-9604 | AMPK-mediated metabolic activation (MOTS-c) + beta-3 AR lipolysis (AOD-9604) |
| Epithalon | Mitochondrial peptide + telomerase activation for combined cellular aging intervention |
| Tesamorelin | GHRH-mediated GH pulse complements MOTS-c metabolic optimization |
Frequently Asked Questions
Explore More
Anti-aging telomerase activator
GH fragment fat metabolism
FDA-approved GHRH analog
Browse all 251 compounds
Build protocols
Precision dosing
